5/22/2026Recent Executive Moves

5/22/2026Bayer Wins China Approval for Kerendia (finerenone) in Heart Failure

5/22/2026Qyuns Therapeutics Expands China Biologics Portfolio With Ustekinumab ...

5/22/2026J&J Wins China Approval for Nipocalimab in Myasthenia Gravis

5/22/2026Nuance Wins China IND Clearance for Actair Allergy Immunotherapy Trial

5/22/2026Pakistan Emerges as New Target for Chinese Pharmaceutical Investment

5/22/2026FDA Warns Chinese API Manufacturer Over Relabeled GLP-1 Ingredients Sh...

5/22/2026Full-Life Raises $150M to Expand Clinical Radiopharma Pipeline and Act...

5/22/2026China Clears First INDs for 25 Novel Drugs Last Week

5/21/2026China to Establish "Whitelist" System to Curb Misuse of Medical Insura...

5/21/2026China Accelerates Stem Cell Race for Parkinson's Disease Therapies

More>>

5/20/2026Global Pharma and China Biotech Race Into a New Era of High-Stakes Lic...

5/19/2026The China question Is Tearing Biotech Apart (STAT)

5/18/2026China's RWE Evolution: From Pilot to Practice (Simon-Kucher)

5/18/2026Nature Analysis Highlights China's Rise as Global Clinical Trial Hub

5/14/2026Pharma CEOs Missing From Trump's China Delegation

5/14/2026Life Sciences a "Sweet Spot" for U.S.-China Cooperation Ahead of Trump...

5/11/2026China Emerges as Global Hub for siRNA Out-Licensing Deals: PharmaDJ

5/5/2026A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...

5/1/2026A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...

4/29/2026China Partnerships Drive Biopharma Deal Surge to $79B in Q1 2026

4/29/2026From fast follower to originator: How Asia is rewiring biopharma innov...

More>>